Literature DB >> 15240881

Template-assisted filament growth by parallel stacking of tau.

Martin Margittai1, Ralf Langen.   

Abstract

Tau filaments are found in >20 neurodegenerative diseases. Yet, because of their enormous molecular weights and poor tendency to form highly ordered 3D crystal lattices, they have evaded high-resolution structure determination. Here, we studied 25 derivatized tau mutants by using electron paramagnetic resonance and fluorescence spectroscopy to report structural details of tau filaments. Based on strong spin exchange and pyrene excimer formation of core residues, we find that individual tau proteins form single molecule layers along the fiber axis that perfectly stack on top of each other by in-register, parallel alignment of beta-strands. We suggest a model of filament growth wherein the existing filament serves as a template for the incoming, unfolded tau molecule, resulting in a new structured layer with maximized hydrogen-bonded contact surface and side-chain stacking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240881      PMCID: PMC478563          DOI: 10.1073/pnas.0401911101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Crystal structures of spin labeled T4 lysozyme mutants: implications for the interpretation of EPR spectra in terms of structure.

Authors:  R Langen; K J Oh; D Cascio; W L Hubbell
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

2.  Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain.

Authors:  J Zurdo; J I Guijarro; J L Jiménez; H R Saibil; C M Dobson
Journal:  J Mol Biol       Date:  2001-08-10       Impact factor: 5.469

Review 3.  Identifying conformational changes with site-directed spin labeling.

Authors:  W L Hubbell; D S Cafiso; C Altenbach
Journal:  Nat Struct Biol       Date:  2000-09

Review 4.  Homotrimeric, beta-stranded viral adhesins and tail proteins.

Authors:  Peter R Weigele; Eben Scanlon; Jonathan King
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

5.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

6.  Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

Authors:  M E King; V Ahuja; L I Binder; J Kuret
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

7.  Fibers of tau fragments, but not full length tau, exhibit a cross beta-structure: implications for the formation of paired helical filaments.

Authors:  A M Giannetti; G Lindwall; M F Chau; M J Radeke; S C Feinstein; L A Kohlstaedt
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

8.  Oxidative regulation of fatty acid-induced tau polymerization.

Authors:  T C Gamblin; M E King; J Kuret; R W Berry; L I Binder
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

9.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

10.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  99 in total

1.  Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.

Authors:  Ayisha Siddiqua; Martin Margittai
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Structure-based design of conformation- and sequence-specific antibodies against amyloid β.

Authors:  Joseph M Perchiacca; Ali Reza A Ladiwala; Moumita Bhattacharya; Peter M Tessier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-14       Impact factor: 11.205

3.  A solenoid design for assessing determinants of parallel β-sheet registration.

Authors:  Ellen M White; Andrew D Miranker
Journal:  Protein Eng Des Sel       Date:  2015-10-20       Impact factor: 1.650

4.  Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau.

Authors:  Anna Pavlova; Chi-Yuan Cheng; Maia Kinnebrew; John Lew; Frederick W Dahlquist; Songi Han
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

5.  Conformational sampling with implicit solvent models: application to the PHF6 peptide in tau protein.

Authors:  Austin Huang; Collin M Stultz
Journal:  Biophys J       Date:  2006-10-13       Impact factor: 4.033

Review 6.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

Review 7.  Solid-state NMR as a probe of amyloid structure.

Authors:  Robert Tycko
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

8.  Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

Authors:  Erin E Congdon; Sohee Kim; Jonathan Bonchak; Tanakorn Songrug; Anastasios Matzavinos; Jeff Kuret
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

9.  Structural and functional studies of truncated hemolysin A from Proteus mirabilis.

Authors:  Todd M Weaver; Joshua A Smith; Jason M Hocking; Lucas J Bailey; Grayson T Wawrzyn; David R Howard; Laura A Sikkink; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

Review 10.  Structural classification of toxic amyloid oligomers.

Authors:  Charles G Glabe
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.